These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36975491)

  • 41. Expression of CD44 splice variants in human skin and epidermal tumours.
    Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
    Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma.
    Poncelet C; Walker F; Madelenat P; Bringuier AF; Scoazec JY; Feldmann G; Darai E
    Hum Pathol; 2001 Nov; 32(11):1190-6. PubMed ID: 11727257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of CD44 variant isoforms, CD44v3 and CD44v6, are associated with prognosis in nasopharyngeal carcinoma.
    Sagawa K; Uwa N; Daimon T; Sakagami M; Tsujimura T
    J Laryngol Otol; 2016 Sep; 130(9):843-9. PubMed ID: 27453283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cx
    Kitamura K; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):133-141. PubMed ID: 35736626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints.
    Wibulswas A; Croft D; Pitsillides AA; Bacarese-Hamilton I; McIntyre P; Genot E; Kramer IM
    Arthritis Rheum; 2002 Aug; 46(8):2059-64. PubMed ID: 12209509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation.
    Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J
    Int J Cancer; 1996 Jun; 69(3):218-24. PubMed ID: 8682591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin.
    Furusawa Y; Yamada S; Itai S; Nakamura T; Takei J; Sano M; Harada H; Fukui M; Kaneko MK; Kato Y
    Biochem Biophys Rep; 2019 Jul; 18():100631. PubMed ID: 30984883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production and characterization of a peptide-based monoclonal antibody against CD44 variant 6.
    Zarei S; Bayat AA; Hadavi R; Mahmoudi AR; Tavangar B; Vojgani Y; Jeddi-Tehrani M; Amirghofran Z
    Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):36-43. PubMed ID: 25723282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
    Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
    Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products.
    Martegani MP; Del Prete F; Gasbarri A; Natali PG; Bartolazzi A
    Am J Pathol; 1999 Jan; 154(1):291-300. PubMed ID: 9916943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal Antibody L
    Yamada S; Itai S; Nakamura T; Yanaka M; Chang YW; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):110-115. PubMed ID: 29608408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PMab-210: A Monoclonal Antibody Against Pig Podoplanin.
    Furusawa Y; Yamada S; Itai S; Sano M; Nakamura T; Yanaka M; Fukui M; Harada H; Mizuno T; Sakai Y; Takasu M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2019 Feb; 38(1):30-36. PubMed ID: 30681406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells.
    Zarcone D; De Rossi G; Tenca C; Marroni P; Mauro FR; Cerruti GM; Albi N; Fiorucci S; Velardi A; Grossi CE
    Haematologica; 1998 Dec; 83(12):1088-98. PubMed ID: 9949626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment of an Anti-CD20 Monoclonal Antibody (C
    Furusawa Y; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2020 Aug; 39(4):112-116. PubMed ID: 32667234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
    Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
    Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal antibodies against human tumor metastasis suppressor gene-1 (TMSG-1): preparation, characterization, and application.
    Fei P; Junyu N; Jiangfeng Y; Jingpin Y; Yuping W; Zhihui H; Jieliang W; Xianglin C; Shaomin Y; Jie Z
    Hybrid Hybridomics; 2004 Oct; 23(5):318-25. PubMed ID: 15672611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological significance and prognostic implication of CD44 and its splice variants (v3 and v6) in colorectal cancer.
    Yan B; Mu Y; Cui M; Liu L
    Transl Cancer Res; 2020 Feb; 9(2):1215-1224. PubMed ID: 35117466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.